Annual ROE
-29.81%
-86.82%-152.29%
December 31, 2023
Summary
- As of February 12, 2025, MLYS annual return on equity is -29.81%, with the most recent change of -86.82% (-152.29%) on December 31, 2023.
- During the last 3 years, MLYS annual ROE has fallen by -125.06% (-131.30%).
- MLYS annual ROE is now -131.30% below its all-time high of 95.25%, reached on December 1, 2020.
Performance
MLYS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-55.92%
-13.31%-31.24%
September 30, 2024
Summary
- As of February 12, 2025, MLYS quarterly return on equity is -55.92%, with the most recent change of -13.31% (-31.24%) on September 30, 2024.
- Over the past year, MLYS quarterly ROE has dropped by -29.44% (-111.18%).
- MLYS quarterly ROE is now -160.67% below its all-time high of 92.17%, reached on June 1, 2022.
Performance
MLYS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MLYS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -152.3% | -111.2% |
| 3 y3 years | -131.3% | -67.5% |
| 5 y5 years | -131.3% | -67.5% |
MLYS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -135.2% | at low | -160.7% | at low |
| 5 y | 5-year | -131.3% | at low | -160.7% | at low |
| alltime | all time | -131.3% | at low | -160.7% | at low |
Mineralys Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -55.92%(+31.2%) |
| Jun 2024 | - | -42.61%(+31.2%) |
| Mar 2024 | - | -32.48%(+22.7%) |
| Dec 2023 | -29.81%(-152.3%) | -26.48%(-7.3%) |
| Sep 2023 | - | -28.55%(-14.5%) |
| Jun 2023 | - | -33.39%(-36.0%) |
| Mar 2023 | - | -52.21%(-183.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | 57.01%(-32.7%) | 62.29%(-25.7%) |
| Sep 2022 | - | 83.84%(-9.0%) |
| Jun 2022 | - | 92.17%(+44.2%) |
| Mar 2022 | - | 63.91%(+106.8%) |
| Dec 2021 | 84.66%(-11.1%) | - |
| Dec 2021 | - | 30.90% |
| Dec 2020 | 95.25% | - |
FAQ
- What is Mineralys Therapeutics annual return on equity?
- What is the all time high annual ROE for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual ROE year-on-year change?
- What is Mineralys Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly ROE year-on-year change?
What is Mineralys Therapeutics annual return on equity?
The current annual ROE of MLYS is -29.81%
What is the all time high annual ROE for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual return on equity is 95.25%
What is Mineralys Therapeutics annual ROE year-on-year change?
Over the past year, MLYS annual return on equity has changed by -86.82% (-152.29%)
What is Mineralys Therapeutics quarterly return on equity?
The current quarterly ROE of MLYS is -55.92%
What is the all time high quarterly ROE for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly return on equity is 92.17%
What is Mineralys Therapeutics quarterly ROE year-on-year change?
Over the past year, MLYS quarterly return on equity has changed by -29.44% (-111.18%)